Solventum Reports Second Quarter 2026 Financial Results

EarningsPositive

AI Analysis

Summary

Solventum reported Q2 2026 earnings with 9.5% organic sales growth and raised full-year 2026 guidance while announcing intent to separate its Health Information Systems business segment.

Financial Highlights

Revenue

2.2% reported sales increase; 9.5% organic sales increase

Guidance

Increased full-year 2026 guidance for organic sales growth, adjusted EPS and free cash flow

Importance:5/10

Sentiment:

0.60

earningsfinancial resultsguidance raisebusiness separationorganic growth

Related Companies

$SOLV

Read the original article

Published by PR Newswire Pharma on August 5, 2026 8:12 PM

Read Original